Safety evaluation of a skin care product containing linoleic acid for atopic dermatitis patients

Sahori Uchi, Miki Moroi, Kenjiro Nakamura, Masutaka Furue

Research output: Contribution to journalArticle

Abstract

In spite of concerns about contact dermatitis, many patients with atopic dermatitis (AD) want to use skin lightning agents to treat increased pigmentation sometimes caused by chronic skin inflammation. Therefore, we tested the safety of a skin lightening agent containing linoleic acid in AD patients. Written informed consent was obtained from 24 AD patients. We first conducted a patch test of the agent on the one positive case, and the other 23 negative cases were then subjected to a half face use test for a month to detect any adverse reactions. Except for 2 cases who failed to visit the hospital and 1 case hospitalized for ectopic pregnancy, 20 cases continued to use the agent for a month. Transient erythema, transient scale, transient eyelid edema, pigmentation at the corners of the mouth, and irritation on the forehead and lips were observed as minor adverse reactions. Although a follow-up is required, these results suggest that this skin lightening agent containing linoleic acid may be an option for AD patients suffering from skin pigmentation.

Original languageEnglish
Pages (from-to)408-411
Number of pages4
JournalNishinihon Journal of Dermatology
Volume73
Issue number4
DOIs
Publication statusPublished - 2011

Fingerprint

Skin Care
Linoleic Acid
Atopic Dermatitis
Safety
Skin
Pigmentation
Lightning
Skin Pigmentation
Patch Tests
Forehead
Ectopic Pregnancy
Contact Dermatitis
Eyelids
Erythema
Lip
Informed Consent
Mouth
Edema
Inflammation

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Safety evaluation of a skin care product containing linoleic acid for atopic dermatitis patients. / Uchi, Sahori; Moroi, Miki; Nakamura, Kenjiro; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 73, No. 4, 2011, p. 408-411.

Research output: Contribution to journalArticle

@article{7c94a90272ed4b3bb54908224a9ad0cd,
title = "Safety evaluation of a skin care product containing linoleic acid for atopic dermatitis patients",
abstract = "In spite of concerns about contact dermatitis, many patients with atopic dermatitis (AD) want to use skin lightning agents to treat increased pigmentation sometimes caused by chronic skin inflammation. Therefore, we tested the safety of a skin lightening agent containing linoleic acid in AD patients. Written informed consent was obtained from 24 AD patients. We first conducted a patch test of the agent on the one positive case, and the other 23 negative cases were then subjected to a half face use test for a month to detect any adverse reactions. Except for 2 cases who failed to visit the hospital and 1 case hospitalized for ectopic pregnancy, 20 cases continued to use the agent for a month. Transient erythema, transient scale, transient eyelid edema, pigmentation at the corners of the mouth, and irritation on the forehead and lips were observed as minor adverse reactions. Although a follow-up is required, these results suggest that this skin lightening agent containing linoleic acid may be an option for AD patients suffering from skin pigmentation.",
author = "Sahori Uchi and Miki Moroi and Kenjiro Nakamura and Masutaka Furue",
year = "2011",
doi = "10.2336/nishinihonhifu.73.408",
language = "English",
volume = "73",
pages = "408--411",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "4",

}

TY - JOUR

T1 - Safety evaluation of a skin care product containing linoleic acid for atopic dermatitis patients

AU - Uchi, Sahori

AU - Moroi, Miki

AU - Nakamura, Kenjiro

AU - Furue, Masutaka

PY - 2011

Y1 - 2011

N2 - In spite of concerns about contact dermatitis, many patients with atopic dermatitis (AD) want to use skin lightning agents to treat increased pigmentation sometimes caused by chronic skin inflammation. Therefore, we tested the safety of a skin lightening agent containing linoleic acid in AD patients. Written informed consent was obtained from 24 AD patients. We first conducted a patch test of the agent on the one positive case, and the other 23 negative cases were then subjected to a half face use test for a month to detect any adverse reactions. Except for 2 cases who failed to visit the hospital and 1 case hospitalized for ectopic pregnancy, 20 cases continued to use the agent for a month. Transient erythema, transient scale, transient eyelid edema, pigmentation at the corners of the mouth, and irritation on the forehead and lips were observed as minor adverse reactions. Although a follow-up is required, these results suggest that this skin lightening agent containing linoleic acid may be an option for AD patients suffering from skin pigmentation.

AB - In spite of concerns about contact dermatitis, many patients with atopic dermatitis (AD) want to use skin lightning agents to treat increased pigmentation sometimes caused by chronic skin inflammation. Therefore, we tested the safety of a skin lightening agent containing linoleic acid in AD patients. Written informed consent was obtained from 24 AD patients. We first conducted a patch test of the agent on the one positive case, and the other 23 negative cases were then subjected to a half face use test for a month to detect any adverse reactions. Except for 2 cases who failed to visit the hospital and 1 case hospitalized for ectopic pregnancy, 20 cases continued to use the agent for a month. Transient erythema, transient scale, transient eyelid edema, pigmentation at the corners of the mouth, and irritation on the forehead and lips were observed as minor adverse reactions. Although a follow-up is required, these results suggest that this skin lightening agent containing linoleic acid may be an option for AD patients suffering from skin pigmentation.

UR - http://www.scopus.com/inward/record.url?scp=80052070882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052070882&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.73.408

DO - 10.2336/nishinihonhifu.73.408

M3 - Article

AN - SCOPUS:80052070882

VL - 73

SP - 408

EP - 411

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 4

ER -